Siga Technologies (SIGA)
(Real Time Quote from BATS)
$7.80 USD
+0.35 (4.70%)
Updated May 14, 2024 04:00 PM ET
After-Market: $7.85 +0.05 (0.64%) 4:18 PM ET
1-Strong Buy of 5 1
A Value A Growth A Momentum A VGM
Brokerage Reports
0 items in cart
Siga Technologies Inc. [SIGA]
Reports for Purchase
Showing records 1 - 20 ( 77 total )
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Optimizing the TPOXX value proposition
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for SIGA 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Siga Technologies Inc.
Industry: Medical - Drugs
International momentum building towards year-end
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
EU gateway to tap into new international orders
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Notable CMO appointment to position for growth
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Second quarter as expected, onward to H223
Provider: Edison Investment Research Limited
Analyst: AATKAR A
Company: Siga Technologies Inc.
Industry: Medical - Drugs
US exercised (stockpile) options are key catalysts
Provider: Edison Investment Research Limited
Analyst: AATKAR A
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Diamond in the rough amid macro weakness
Provider: Edison Investment Research Limited
Analyst: AATKAR A
Company: Siga Technologies Inc.
Industry: Medical - Drugs
US stockpiles front and center in Q1 and FY23
Provider: Edison Investment Research Limited
Analyst: Research Department
Company: Siga Technologies Inc.
Industry: Medical - Drugs
US stockpiles front and center in Q1 and FY23
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Solid results marked by revenue diversification
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Solid Q322, underpinned by international traction
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
TPOXX trials launched in treating monkeypox
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Second contract win from the US DoD in 2022
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Monkeypox concern drives international TPOXX win
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Company: Siga Technologies Inc.
Industry: Medical - Drugs
BARDA exercises first option for IV TPOXX
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S